Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Applied Therapeutics (APLT) Net Income (2023 - 2025)

Historic Net Income for Applied Therapeutics (APLT) over the last 3 years, with Q3 2025 value amounting to -$16.6 million.

  • Applied Therapeutics' Net Income rose 4147.11% to -$16.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$96.3 million, marking a year-over-year decrease of 777.86%. This contributed to the annual value of -$100.8 million for FY2024, which is 5953.17% down from last year.
  • Applied Therapeutics' Net Income amounted to -$16.6 million in Q3 2025, which was up 4147.11% from -$22.7 million recorded in Q2 2025.
  • Applied Therapeutics' Net Income's 5-year high stood at -$10.6 million during Q1 2023, with a 5-year trough of -$32.1 million in Q4 2024.
  • For the 3-year period, Applied Therapeutics' Net Income averaged around -$20.7 million, with its median value being -$20.5 million (2024).
  • As far as peak fluctuations go, Applied Therapeutics' Net Income plummeted by 9278.93% in 2024, and later soared by 4147.11% in 2025.
  • Quarter analysis of 3 years shows Applied Therapeutics' Net Income stood at -$20.7 million in 2023, then plummeted by 55.21% to -$32.1 million in 2024, then soared by 48.18% to -$16.6 million in 2025.
  • Its Net Income was -$16.6 million in Q3 2025, compared to -$22.7 million in Q2 2025 and -$24.9 million in Q1 2025.